For the last 20 years, David Ring founded several successful high-tech companies, including Colu & eToro, with a total fundraising of $200M. He was also part of the founding team at 888.com.
David holds B.Sc. in electronics from the Technion, M.Sc. in computer science from IDC, and an MBA in finance from Manchester business school.
David is also an angel investor, serves as board member at several companies, and chairman of MIT enterprise Israel forum.
David is deeply knowledgeable in the fin-tech industry, social platforms, blockchain technologies, and the gaming industry.
Amir is an investor and entrepreneur, and works with several companies as mentor and advisor.
Amir joined in January 2015 Microsoft Israel R&D Center as General Manager, Engineering following the acquisition of Equivio.
Amir was a co-founder and CEO of Equivio. Equivio provides text analytics solutions for legal and compliance based on a court-approved machine learning platform for business process of e-discovery.
Prior to Equivio, Amir co-founded and was vice president of marketing and business development at Xyleme, a company specializing in XML-based content management systems. At Xyleme, Amir was responsible for product strategy, the development of sales channels, and the penetration into new markets and regions.
Before Xyleme, Amir served as a director of software development at Amdocs. In this role, Amir led billing system projects for communications companies in the U.S., Europe and the Middle East.
Amir holds bachelor's and master's degrees in computer science from the Technion in Israel, and an MBA from the University of Toronto.
Mr. Shavit is the Chairman of GenCell’s Board of Directors.
Gil is passionate about bringing fuel cell power solutions to new businesses and industries. With more than 25 years of experience in establishing innovative Israeli technology companies, he has led joint ventures with global firms such as Phillips and G4S Brazil. Gil has a B.Sc. in Computers and Electronics from the Ben Gurion University of the Negev.
Martin Gerstel is Chairman of Compugen Ltd., a publicly owned drug and diagnostic discovery company, Evogene Ltd., a publicly owned agbio company, of Keddem Bioscience, a privately owned drug discovery company and Co-Chairman of Itamar Medical, a publicly owned medical device company, all of which are headquartered in Israel. Prior to relocating to Israel in 1994, Mr. Gerstel was the Co-Chairman and CEO of ALZA Corporation, a pharmaceutical company based on advanced drug delivery. In addition, Mr. Gerstel currently serves as a director of YEDA Technology Transfer, Yissum Technologies and the Foundation for the US National Medals of Science and Technology. He is a member of the Board of Governors and the Executive Committee of the Weizmann Institute of Science and the Board of Governors of the Hebrew University of Jerusalem, and is an advisor to the Burrill Life Science Funds and to the Board of the Israel-U.S. BiNational Industrial Research and Development (“BIRD”) Foundation. Mr. Gerstel is a graduate of Yale University and the Stanford Graduate School of Business.
Yaniv Corem is the Co-Founder of NUKADIMA, a corporate catalyst focused on helping organizations build, test and deploy new ventures. Yaniv is also an Entrepreneur-in-Residence at Fung Academy where he supports various innovation projects like Explorium, AI in Action and GBG TechLinks. Yaniv was a visiting researcher in the Changing Places Group at the MIT Media Lab where he worked on Lego-based urban design tools. Prior to joining the Media Lab, Yaniv led the Crowd Computing work in the Social Technologies Group at IBM Research Haifa.
Yaniv holds a Bachelor degree in Architecture and Urban Planning from the Technion - Israel Institute of Technology - and two Master’s degree in Architecture and Computer Science from the Massachusetts Institute of Technology.
Yaniv is married to Gila, a Product and UX designer, and a father of three - Yotam, Abigail and Ella.